Skip to main content

CTTC

Ancora Innovation proposal submissions open March 14

Feb. 26, 2019—This is the second request for proposals to Ancora since Vanderbilt and Deerfield launched their collaboration in 2018 with a commitment from Deerfield of up to $65 million in initial funding over five years to support promising drug discovery research.

Read more


Therapeutic Antibody Discovery and Development event is Jan. 23

Jan. 2, 2019—Vanderbilt's Center for Technology Transfer and Commercialization, the Vanderbilt Institute of Chemical Biology and Deerfield will bring together experts in discovery and development of antibody therapeutics Jan. 23 to discuss and review state-of-the-art developments in the field.

Read more


Therapeutic Antibody Discovery and Development event is Jan. 23

Dec. 19, 2018—The event aims to expose faculty and staff to therapeutic antibody discovery in an academic setting and foster interest in submission of innovative ideas for antibody targets through an upcoming RFP for Ancora, the collaboration between Vanderbilt and Deerfield.

Read more


FDA approves device based on Vanderbilt invention to ID parathyroid during head and neck surgeries

Dec. 17, 2018—Ten years after Professor of Biomedical Engineering Anita Mahadevan-Jansen discovered that parathyroid tissues glow under near-infrared light, the FDA has approved a device based on the technology for surgical use.

Read more


Ancora announces major funding awards to support Vanderbilt drug discovery research

Nov. 26, 2018—Ancora Innovation, LLC, the new collaboration between Vanderbilt and Deerfield Management established earlier this year, has completed its inaugural proposal review process and announced two projects selected for funding.

Read more


Business Valuation Seminar 2018 at Wond’ry Nov. 7

Oct. 19, 2018—Nashville-based valuation expert Glenn Perdue will lead a seminar on the valuation process of early-stage businesses on Wednesday, Nov. 7, at the Wond'ry.

Read more


CTTC to host session on funding opportunities for physicians, scientists developing new therapies

Oct. 7, 2018—Vanderbilt's Center for Technology Transfer and Commercialization will host a session on Oct. 16 with the Harrington Discovery Institute to explore funding opportunities for physicians and scientists who are developing new therapies.

Read more


Slides can help faculty with Ancora proposal submissions

May. 10, 2018—The Office of the Vice Provost for Research and the Center for Technology Transfer and Commercialization have posted informational slides for faculty preparing pre-proposal submissions in response to the inaugural Ancora request for proposals.

Read more


Ancora inaugural request for proposals announced

Apr. 20, 2018—The Office of the Vice Provost for Research and Deerfield Management announce the inaugural request for proposals for Ancora Innovation, LLC, with a due date of June 4. An RFP information session is scheduled from 2 to 3:30 p.m. Friday, April 27, at Sarratt Student Center, Room 325.

Read more


‘Collaborating with industry to advance basic science research’ topic of April 6 talk

Apr. 4, 2018—The Center for Technology Transfer and Commercialization's Alan Bentley will discuss emerging initiatives at Vanderbilt to engage industry more effectively, and a team from Deerfield Management will explain its collaborative approach to working with premier academic institutions to catalyze early stage therapeutic development.

Read more


Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

Mar. 14, 2018—New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.

Read more


Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

Read more


Upcoming Events

MORE EVENTS »